<DOC>
	<DOCNO>NCT01391286</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost solution 0.03 % compare vehicle Japanese adult hypotrichosis eyelash follow chemotherapy treatment .</brief_summary>
	<brief_title>Safety Efficacy Study Bimatoprost Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Have inadequate eyelash due chemotherapy treatment Treated solid tumor breast colorectal cancer early stage cancer spread outside primary organ ( eg , stage 1 , 2 3a breast cancer ) Have complete chemotherapy treatment least 4 week 24 week side effect relate chemotherapy recover , improve maintain , exception hair loss Any disease/infection/abnormality eye area around eye Any ocular surgery within 3 month anticipate need ocular surgery study Any permanent eyeliner implant kind anticipate use false eyelashes Any semipermanent eyelash tint , dye , curl eyelash extension application within 3 month Use overthecounter eyelash growth product within 6 month use prescription eyelash growth product Use treatment may affect hair growth ( eg , minoxidil ) within 6 month except prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>